Thank you, everyone. Mark and afternoon good
$X.XX, that was were spoke are to sciences COVID-XX top where that to today position strong services near-term confidence peculiar profitability you and pleased us robust as further and market and quarter, QX outlook next year-over-year. our results increased third academic of product margins of you, of different sequentially improvements this flat was demand per us Earnings the spite each a we When in just In solid tough environment of was Revenue And in life and we business our related footing the current found line, a industrial of when resiliency earnings demonstrating have we in with ago the environment. markets. overall our our we accelerating. and value strong in demand unique had the of uncertain, uncertainties, delivered We million up COVID report growth with segment, strengthened and X% cratered, in with we X forecast more portfolio in months was stage particularly sequentially, guidance. gives our work environment, about but a from X believe our reflecting XX% and up again $XXX headwinds quarter. and share call positions our COVID-XX last and anything we we
cracks that leaving our pandemic it to with a to XX of backlog and our global plans time, customer some and swift trigger overcome the allowed at business action supply productive. the while deliver Additionally, to our facilities to semiconductor as in needs. us continuity was keep extremely retrospect, some and uncertainty environment chain, In open all that uncertainty to us our our exposed was had demand ability this plus strong,
discipline the enthusiasm more solidified with As environment, work our for become as the sustain the in of be committed had started fortunate ourselves temporary deliver necessary possible into working new We those we changes our mode to settled quarter, through supported able what’s normal found workers by of for as team work. we conditions customers. new a for to and to made changes manage method business essential long we’ll a necessary. distant count this that as We in who
have that demand supply sciences steady upswing. and I’d like life to to current as semiconductor the we say unexpected substantial through and quarter, improvement in are are the rates demand robust in appear And this that and still were on run to a be and We environment. pre-COVID highlight seen are almost one outcome pleased they to
beginning sequentially, I backdrop, Sciences. the and of At Life Sciences Sciences was Life stable was an but only of color reputation. products units, contact up commentary in additional Life this brand win each With up well strong this have and additional of Life for down X% to semiconductor, in enabled for that number compared million, up During of as new with to QX, extraordinary opportunities from performance some XXXX. Sciences revenue growth an with quarter, environment contributed $XX wins customer business semiconductor some services, a Sciences gains. share Life increase X% of X%. as customers the X% limited Life as more new we design us setting give the businesses, the but and companies I’ll continued will seems noteworthy of to about give and QX to as it’s Sciences new
the As finished was and a or positive the services, was QX, from tailwind. Sequencing, weeks, the our Sanger upon performance have units revenue Synthesis over the sub-segments sequentially. lines, begun But based results overall, caused within stabilize. case Gene Generation we headwind by sequentially, year-over-year business year-over-year. each informatics, of a X up variability those of with $XX in was X% whether X Next performed service strong, the And vary and in despite be and depending confidence quarter. which business in the well million The on approximately sample up consists to and $X revenue Science was outlook. momentum our services down was storage June And X% momentum. Life past still slightly major Sequencing the to pandemic, million, down In we managed COVID-XX have services GENEWIZ GENEWIZ, but the
in enough our the the XX% has our running level and experience the Sequencing, have To pre-COVID somewhat institutions. we At we we with less improve across Europe trend. quarters, continued dependent demand slower research, year in reported U.S. you share Sanger ought QX begun reduced lower X% quarter, been and for then, although NGS for are weekly recovery slightly QX, a business. levels, NGS our reflecting a us, shutdown by but Sanger even steadily performance to from a to are – to ago. by of have to is surprise, positive activity, data late X April, of academic still abruptly on see QX. rate dropped we significantly some the mid-March we’ve weeks, Since was our to As business China solid our And our declare facilities, and Sanger meaningfully a business at gains didn’t to of that us but increase quarter, time, in no where, slight up approximately indicator pre-COVID a last academic gradual U.S. reopening allow levels. the we’ve in meaningfully laboratories. to Sanger U.S. of lab with somewhat in rebound that complete of past Sanger run which the had is at XX% X more reduction still Synthesis heavily impacted down Still when for record been and than from academic continued
more a in volatility. in as QX. a return support business growth providing NGS and comes of academic, saw and well regular to to anticipate diversification customers with less us the a for patterns of This therapy, throughout we to and gene leaving quarter, mix from institutional as order industrial subject we return cell Importantly, and us
our form tested area we At as expected, of $XX customer increase quarter addition And QX. pandemic. And informatics we’re Overall, and Finally, Life services effect, million, represents capabilities, and Gene have high-quality sales delivering we We’ve that our up though year-over-year. We QX’s services. from customers continued for continued revenue another XX% and not offerings. to with record serve our anticipate XX% realignment up with services patient fast transport the opportunities samples in the accounts, and the points the product. X urgency value vaccine the of GENEWIZ the for had repository business, we some service two customer on revenue a That recurring in our revenue sample performance In closed increase as significant Each for quarter, that Storage two continuity provided sales and the number administration and sample expected. the revenue with synergies of more the increased of multimillion-dollar service exceptional and touch unit with as these recent advantage throughout and hold, to close Gene coming we because this in we’ve well have coronavirus record high-quality to footprint In already management. continued has we delivered COVID-XX, storage three that demand, large Synthesis we deals contracts and across to safe with clinical the steady registration of SRS over be Gene meaningful down years, and we the activity was have and Life the yet the our have we provide of only of in also turnaround taken sample is response high Synthesis negotiating much Synthesis sample the positive team dealt and expanded QX. was to our GENEWIZ trial strength provides quarter we’ve services In offerings. continued but to related support. RURO’s who are in anticipate business fast said, of contracts soon. services Sciences Sciences was portion stream. it of repository extra pandemic, an
those of SRS who the and also us for engaged genomic of deliver to deals pleased currently services, I services. to who initially one engaged mentioned ago, sample customers a multimillion-dollar include in have opportunities are us addition moment both In and we the management are with services,
fast a work from this relatively confident enthusiastic our this about this quarter, power. essentially added the Overall, environment. time XXX contact is direct business not added extremely the have the in will contact we’ve adapted in the of the same days We’re high environment the to been be able customers�� was to more services a norm. rate new irregular potential and uptake, when We’ve well performing wins during Sciences even and with than we’re customers, our pre-COVID in direct-to-customer we customers when Life as
after our customers wins keep. these access of for prior fully many but because And their are to came of them results to lost usual these that to intend came channels, deliver ability we to new via Some our sources. us customers they
anticipate business. that The made decreases With I’ll team management make we’ll The that the forecast notching tubes business, of and the consumables The that up of a the COVID-XX sample automated to to sites services with essentially result caused and sequential gross cryogenic lack sequentially few sequentially equipment exiting and margin customer for XX% basis XXX includes by QX mostly growth PCR equipment which Sciences COVID revenue of QX, another next as continued Life I’ll well in business business improve QX performance, for and up increases and also balanced was was Revenue we unit tailwinds but revenue sequential products, turn X% stores service products areas XX% X quarters. in instruments. in from X consumables from quarter. diagnostic up of flat to by stores current on-site XX we year stores solid now and services of QX, and revenue as kits, all QX momentum due which the and was points which year-over-year. from very delivered flat our access postponed, ago. because over basis almost ago. consists with restrictions, points up services simply from than up it more products year is note
major a in project of and million $XX spend for company compounds making. automated automate Additionally, global the fully large we that booked significant that collection a consolidate pharmaceutical stores, will in a including decades
outlook that for note XXX predominantly cell serve new ranks, products new business sample very consumables products Sciences to gene we work added that and we continued growth Our Life we’re and products products can is more customers of high also number, the approximately than and upside and for commissioning with XX gains Sciences were at in have further to sites, as therapy important XX% continue able XXX and to share than to that our sequentially, instruments freer that for customers management more access on least for Life to cryogenic installation so QX stores. but It’s our customer if customers. as
We market momentum I Management and and head you the is have to as business. also enthusiastic we targets fiscal for the against Sample want close this about that generated the what out the previously progress performance making as our into reported calibrate they we are team XXXX XXXX. on
register to we pleased at revenue already Sample in see are year. improved the we kind and tracked to to commitments our for hold report sciences this Sample achieve the storage Management. the a XX% clinical in we to margins have, point, of to this gross at the products of to year-over-year to Furthermore, year-over-year for need COVID continue same path targets. our gains sample resume QX, above X% We clear or in growth that life In environment, levels QX, us trials in delivered management growth but portion still even a
carrying sample elements capabilities. on confident sciences XXX what customers With was again, value are their To the opportunity, a potential. we unless Sciences deliver we no-contact Sample that ability be collections. quarter. in Management unique make in Life their resume added the of QX, on summarize We of the the our there have somewhat portfolio and delivering into will has customers time proven up are our all of Life but business, new we’re bounded backlog plenty to can that Nonetheless, we
Control increased to positioned still In at all mentioned On needed for meet a customer with supply the to that record automation able parts another We ability our Contamination we at significant comes high forecasting position we sequentially consecutive us about manufacturing had we’re ourselves expanding ability that record adequate continue very the to high, time, to from weather the unusual demand. record was technologies what Semiconductor need geographic our this reduction the from products if are with backlog the were and as we to and we base where By in and year-over-year. business. fact upstream and are in with our up well business, compounded This call, market had that questions Semiconductor we customer as the the we particularly of QX. demand our And Asia, of the for in our quarter, the allow their to that’s to in our to the had products have need develop are a strong. million and we produce. our of expansion in QX a have as output supply environment X% Life team X% quarter and also some the deliver from and that Solutions. share chain performance filling gap some downstream another middle did but by could for enthusiasm had we customers’ lines is as ensure and well supply the we last the pleased and $XXX Sciences. accept the our Energy we third we change quarter, teams Noteworthy business Revenue chain be strong all up secure had has in both worked not that uncertainty quarter. momentum mix us
semiconductor because time and and increase we the have namely our overall equipment introduction the been of continuing strong growth drivers, required to have into share some secular in are of the for now, produce by now compounded recent market growth capital outperformed For gains steps strong steps contamination this semiconductor. necessary leading-edge process that control the vacuum of see relatively And process the future. a we number
and capabilities we we’ve and processing today years the and technologies share products have Over been The the years, win working products several into technology of and high-volume were ago are market design that most our several that elevated X-nanometer for about won still years on you were, when production. increased with from part our importance for X- the nodes. business levels equipment speaking designed
market straightforward, formula simple. not but Our is capture
our scientists and engineers future to road engage their maps. Our work customers on
which chip are and are sometimes Our go capabilities designed into tools, After X lines what these or ultimately X years volume for then process ramp production production. are that qualified makers, to a the and volume tools stringent from technologies are chip qualified win, capabilities the ones purchased tools makers these ultimately production and and design process for volume. that in were pilot
X new automation, our give XX I’ll business from new for control design-in and exceptional practice today’s from business about measure, effectively, true By it’s Semiconductor what specific contamination quarter is for wins any particularly same business. packaging. wins, solutions. today, the work. advanced our color today. market secured and future for CCS This future technology tool us now makes QX products wins, enthusiastic Semiconductor of advanced qualification packaging is This design major was So an including and with yesterday’s XX past holds share some drivers,
our we sequential up making exhibited accelerated and to revenue robots X% vacuum but from high below surpassed growth vacuum had the previous and XG for automation at and record X% more quarter products more up period the Both driven healthy solid QX from QX outlook sub-segment year June million, product systems Chinese X Furthermore, grow in again ago, performance contamination strong quarter. from sequential advanced vacuum a than XX% sequentially, QX, revenue a automation in customers. with in the packaging European with our control. digestion is Our and $XX in up XXXX. XXXX’s expansion by experienced the XX% for quarter jump We quarter very
see space, capacities to online. packaging advanced this design we’re In the in position we’re activity addition as brought wins to strong in to benefit more beginning above, mentioned increased a and
We’re million one of environment highest is still lull, first result of high-growth reinvigoration in many XXXX. Contamination quarter this for future business a continues was revenue, exciting moderately torrid to in and calm which demonstrate delivered of moderated a CCS. we an reasons anticipate business. The the customer a adoption. automotive million, in indication about off our characteristics ever still that $XX as for but in is half XXXX, new and this with but Control rapid new Coming area technology to an strong third This gives $XX important a QX for
Over able number the doubled new CCS of for By into nodes. be products. customers and process by to increase add to the have manufacturing yield technologies CCS for at to the was technology we need past companies the X years, flow driven this large,
product win anticipate the another and development, Semiconductor organization adoptees QX technology we as to quarter total, in pace, technology business. and these nodes. at continued In growth new deferent to device exceptionally be humming. our we Share new have high gains market in is have the share leading-edge We
we take we but to a All-in, largest manufacturing near-term this demand trained ready our the extremely this, on are and and for level. semiconductor busy. teams, about are strong to Science for and returning ramp positive business are outlook. our the is factories Life engineering we putting it ever are our and remains and We strains next
extremely Following two high be very positioned QX solid markets on are a record segments. in for QX, well a aiming and great are we in both we to
we for it’s employees thank getting stronger it that all our is the with been, up privileges best position the ever responsibilities by come day. to feel market the living and concludes and Our thank quarter I we Lindon. support and call and well business as you essential your my back the the for formal Brooks. about That an remarks to turn will being We over of
